Summary:
A randomized, open-label, comparative trial comparing the incidence of hypophosphatemia in relation to treatment with iron isomaltoside and ferric carboxymaltose in subjects with iron deficiency anemia
Qualified Participants Must:
• Have iron deficiency anemia
•
Stopped taking Iron in the last 9 months due to intolerance or ineffectiveness
•
Not undergone IV Iron infusion in the last 30 days
Qualified Participants May Receive:
Reimbursement up to $50.00 per visit for costs related to time and travel